- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
13. In regulation 34 of the principal Regulations (deferral of consideration of applications for inclusion in a pharmaceutical list on fitness grounds)—
(a)before paragraph (1), insert the following paragraph—
“(A1) In this regulation, “A” means, where an application for inclusion in a pharmaceutical list is made by a person who is—
(a)an individual, the individual making the application;
(b)a partnership, any partner in the partnership making the application; or
(c)a body corporate—
(i)except for the purposes of paragraph (1)(b), (c)(ii), (e), (g), (i) and (k), the body corporate making the application, and
(ii)any director or superintendent of the body corporate making the application.”; and
(b)in paragraph (1)—
(i)omit “(A)”,
(ii)in sub-paragraph (a)—
(aa)omit “(or where A is a body corporate, in respect of A or any director or superintendent of A)”, and
(bb)for “A’s removal from its pharmaceutical list, if A” substitute “the person’s removal from the pharmaceutical list, if the person”,
(iii)in sub-paragraph (b), for “A’s removal from its pharmaceutical list, if A” substitute “the person’s removal from the pharmaceutical list, if the person”,
(iv)in sub-paragraph (c)—
(aa)in paragraph (i), omit “(or where A is a body corporate, any director or superintendent of A’s)”,
(bb)in paragraph (ii), omit “(or where A is a body corporate, any director or superintendent of A)”, and
(cc)for “A from the pharmaceutical list if A” substitute “the person from the pharmaceutical list if the person”,
(v)in sub-paragraphs (d), (j) and (k), omit “(and where A is a body corporate, any director or superintendent of A)”,
(vi)in sub-paragraph (e), omit “(or where A is a body corporate, any director or superintendent of A)”,
(vii)in sub-paragraph (f)—
(aa)omit “(or where A is a body corporate, by A or any director or superintendent of A)”, and
(bb)for “A from the pharmaceutical list if A” substitute “the person from the pharmaceutical list if the person”,
(viii)in sub-paragraph (g)—
(aa)omit “(or where A is a body corporate, any director or superintendent of A)”, and
(bb)for “A from the pharmaceutical list if A” substitute “the person from the pharmaceutical list if the person”,
(ix)in sub-paragraph (h)—
(aa)omit “(and where A is a body corporate, any director or superintendent of A)”, and
(bb)for “A from the pharmaceutical list if A” substitute “the person from the pharmaceutical list if the person”,
(x)in sub-paragraph (i)—
(aa)omit “(and where A is a body corporate, any director or superintendent of A)”, and
(bb)for “A from the pharmaceutical list if A” substitute “the person from the pharmaceutical list if the person”, and
(xi)in sub-paragraph (l)(ii), for “A” substitute “the applicant”.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: